The Good And Bad News When It Comes To EU Notified Bodies’ Designation Capacity
Executive Summary
The entire medtech sector is all too aware of the lack of capacity among notified bodies to support the EU medical device and IVD regulations. But what really matters is how much notified body capacity there is in a given product area as this will have the most influence on conformity assessment timelines for individual products.
You may also be interested in...
Extensive EU Medtech Regulatory Survey Reveals Scale Of MDR Hurdles And Where Problems Lie
MedTech Europe says solutions are still urgently needed to ensure the MDR is on course and warns that 50% of companies are deprioritizing the EU as launch market, potentially denying EU citizens vital health care.
EU Reference Laboratory Candidates Invited To Apply In Context of IVDR Regulation
The highest risk IVDs are due to receive an extra layer of regulatory scrutiny in the EU. But it is taking a long time to set up the structures needed.
Latest Italian Designation Means Germany And Italy Are Home To Half EU’s MDR Notified Bodies
While each new designation of a notified bodies in the medtech space is good news, many more organizations are needed rapidly to help manage growing demand. Capacity warnings continue.